×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海应用物理研究所 [2]
武汉大学 [2]
吉林大学白求恩第一医... [2]
吉林大学白求恩第三医... [2]
西安交通大学 [1]
成都生物研究所 [1]
更多...
内容类型
期刊论文 [17]
发表日期
2019 [17]
学科主题
Food Scien... [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共17条,第1-10条
帮助
限定条件
发表日期:2019
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Petchiether A attenuates obstructive nephropathy by suppressing TGF-ss/Smad3 and NF-kappa B signalling
期刊论文
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 卷号: 23, 期号: 8, 页码: 5576-5587
作者:
You, Yong-Ke
;
Luo, Qi
;
Wu, Wei-Feng
;
Zhang, Jiao-Jiao
;
Zhu, Hong-Jian
收藏
  |  
浏览/下载:82/0
  |  
提交时间:2019/10/14
fibrosis
NF-kappa B
obstructive nephropathy
petchiether A
TGF-ss/Smad3
Combining an in silico approach with an animal experiment to investigate the protective effect of troxerutin for treating acute lung injury
期刊论文
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 卷号: 19, 页码: 11
作者:
Li, Ying
;
Ma, Pan
;
Fu, Jin
;
Wu, Jingjing
;
Wu, Xue
收藏
  |  
浏览/下载:64/0
  |  
提交时间:2019/12/02
Troxerutin
In silico prediction
Acute lung injury
Protective effect
Inflammatory response
Identification, characterisation and preliminary functional analysis of IRAK-M in grass carp (Ctenopharyngodon idella)
期刊论文
FISH & SHELLFISH IMMUNOLOGY, 2019, 卷号: 84, 页码: 312-321
作者:
Chu, Pengfei
;
He, Libo
;
Zhu, Denghui
;
Chen, Liangming
;
Huang, Rong
收藏
  |  
浏览/下载:66/0
  |  
提交时间:2019/07/01
Grass carp
IRAK-M
Innate immune
Subcellular localisation
MyD88
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
;
Jiang, Z.
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2019/12/04
tumour necrosis factor-alpha
DMARD
certolizumab pegol
rheumatoid arthritis
Chinese
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
;
Jiang, Z.
收藏
  |  
浏览/下载:39/0
  |  
提交时间:2019/12/05
tumour necrosis factor-alpha
DMARD
certolizumab pegol
rheumatoid arthritis
Chinese
Tumour necrosis factor-alpha gene-308 G > A and-238 G > A polymorphisms are associated with susceptibility to irritable bowel syndrome and drug efficacy in children
期刊论文
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 卷号: 44, 期号: 2
作者:
Sun, Mei-Hua
;
Sun, Li-Qun
;
Guo, Gong-Liang
;
Zhang, Sai
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2019/12/05
-238 G > A
-308 G > A
drug efficacy
gene polymorphism
irritable bowel syndrome
susceptibility
tumour necrosis factor-alpha
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:
Li, X.
;
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2019/12/05
tumour necrosis factor-alpha
DMARD
certolizumab pegol
rheumatoid arthritis
Chinese
Tumour necrosis factor-alpha gene-308 G > A and-238 G > A polymorphisms are associated with susceptibility to irritable bowel syndrome and drug efficacy in children
期刊论文
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 卷号: 44, 期号: 2
作者:
Sun, Li-Qun
;
Zhang, Sai
;
Sun, Mei-Hua
;
Guo, Gong-Liang
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/05
-238 G > A
-308 G > A
drug efficacy
gene polymorphism
irritable bowel syndrome
susceptibility
tumour necrosis factor-alpha
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
;
Jiang, Z.
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2019/12/05
tumour necrosis factor-alpha
DMARD
certolizumab pegol
rheumatoid arthritis
Chinese
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 页码: 227-234
作者:
Bi, L.
;
Li, Y.
;
He, L.
;
Xu, H.
;
Jiang, Z.
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/11/19
rheumatoid arthritis
certolizumab pegol
tumour necrosis factor-alpha
DMARD
Chinese
©版权所有 ©2017 CSpace - Powered by
CSpace